Shared Care Guidelines
Sucroferric oxyhydroxide (oral) for hyperphosphataemia in adult patients with end stage renal failure requiring renal replacement therapy
This shared care guideline has been produced by Hertfordshire and West Essex ICB. It has been accepted and ratified by BLMK APC (June 2024) for use in patients who have a GP within the BLMK area and who are under the care of the Renal Unit at East and North Herts NHS Trust.
Approved by BLMK APC June 2024
Guideline Categories: Renal
Guideline Areas: Bedfordshire, Luton, Milton Keynes
Guideline Tags: end stage, hyperphosphataemia, renal failure, sucroferric, Sucroferric oxyhydroxide
Please use the search box to search the whole site if you can't find what you're looking for:
